These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15700180)

  • 41. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.
    Pettegrew JW; Panchalingam K; Moossy J; Martinez J; Rao G; Boller F
    Arch Neurol; 1988 Oct; 45(10):1093-6. PubMed ID: 3178529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorus magnetic resonance spectroscopy in malformations of cortical development.
    Andrade CS; Otaduy MC; Valente KD; Maia DF; Park EJ; Valério RM; Tsunemi MH; Leite CC
    Epilepsia; 2011 Dec; 52(12):2276-84. PubMed ID: 21973076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
    Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
    Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
    Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
    Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology.
    Sweet RA; Panchalingam K; Pettegrew JW; McClure RJ; Hamilton RL; Lopez OL; Kaufer DI; DeKosky ST; Klunk WE
    Neurobiol Aging; 2002; 23(4):547-53. PubMed ID: 12009504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence of biochemical and biomagnetic interactions in Alzheimer's disease: an MEG and MR spectroscopy study.
    Maestú F; García-Segura J; Ortiz T; Montoya J; Fernández A; Gil-Gregorio P; Campo P; Fernández S; Viaño J; Portera A
    Dement Geriatr Cogn Disord; 2005; 20(2-3):145-52. PubMed ID: 16020943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease.
    Newberg A; Cotter A; Udeshi M; Brinkman F; Glosser G; Alavi A; Clark C
    Nucl Med Commun; 2003 Jul; 24(7):785-90. PubMed ID: 12813197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis.
    Yildiz A; Sachs GS; Dorer DJ; Renshaw PF
    Psychiatry Res; 2001 May; 106(3):181-91. PubMed ID: 11382540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
    JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease].
    Zhang XQ; Min BQ; Ma YC; Yang PJ; Li DP
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):100-2. PubMed ID: 12812674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.
    Zhu X; Cao L; Hu X; Dong Y; Wang H; Liu F; Sun Z
    Clin Neurol Neurosurg; 2015 Mar; 130():80-5. PubMed ID: 25590663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's Disease.
    Chang YT; Huang CW; Chen NC; Lin KJ; Huang SH; Chang YH; Hsu SW; Chang WN; Lui CC; Hsu CW; Chang CC
    PLoS One; 2016; 11(2):e0149056. PubMed ID: 26872386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia.
    Puri BK; Counsell SJ; Hamilton G
    Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):233-5. PubMed ID: 18842398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment.
    Leach MO; Verrill M; Glaholm J; Smith TA; Collins DJ; Payne GS; Sharp JC; Ronen SM; McCready VR; Powles TJ; Smith IE
    NMR Biomed; 1998 Nov; 11(7):314-40. PubMed ID: 9859939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
    Mandal PK; Saharan S; Tripathi M; Murari G
    Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations between CAMCOG-R subscale performance and formal education attainment in South African older adults.
    James KA; Grace LK; Thomas KG; Combrinck MI
    Int Psychogeriatr; 2014 Nov; ():1-10. PubMed ID: 25382591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.